Alkem Laboratories gets nod to close operations at Baddi facility

20 Sep 2021 Evaluate

Alkem Laboratories has received approval to close the operations at Beta Block (Unit II) manufacturing facility located at Baddi. The Beta Block (Unit-II) manufacturing facility at Baddi mainly catered to domestic market for Injections and was significantly underutilized. To avoid operating expenditure in Baddi, it is decided to discontinue the manufacturing operations at this facility, pursuant to the date of closure this facility shall be used as a warehouse.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.

Alkem Laboratories Share Price

5409.65 -69.80 (-1.27%)
24-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1817.60
Dr. Reddys Lab 1351.25
Cipla 1475.90
Lupin 2168.30
Zydus Lifesciences 964.40
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.